PALLIATIVE LASER THERAPY FOR TUMORS OF THE GASTROINTESTINAL-TRACT

被引:6
作者
KRASNER, N [1 ]
机构
[1] WALTON HOSP, LIVERPOOL L9 1AE, MERSEYSIDE, ENGLAND
来源
BAILLIERES CLINICAL GASTROENTEROLOGY | 1991年 / 5卷 / 01期
关键词
D O I
10.1016/0950-3528(91)90005-L
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The argon ion and Nd:YAG lasers were used initially in the mid 1970s to produce haemostasis in acutely bleeding peptic ulcers. With the evolution of treatment techniques, the main area of use of the Nd: YAG laser has now become the palliation of upper and lower GI malignancies. Thermal ablation of tumours may be achieved endoscopically by non-contact laser application at high power, or in the contact mode using artificial sapphire probes at much lower energy levels. Still lower powers can be employed therapeutically using interstitial hyperthermia, and this is best applied endoscopically to exophytic tumour nodules in the gut lumen or to tumours localized ultrasonically in solid organs, such as the liver or pancreas. PDT involves destruction of previously photosensitized tumours by the cytotoxic action of singlet oxygen released on exposure of the neoplastic tissue to light of an appropriate wavelength. Although the theory is attractive, the available experimental and clinical information suggests that treatment should, for the present, be confined to small or early malignancies whose depth of invasion can be verified by endoscopic ultrasound or other imaging techniques. PDT carries the biological advantage of healing by regeneration with preservation of connective tissue stroma, while the Nd: YAG laser causes destruction by thermal coagulation or vaporization and subsequent healing by fibrosis. Laser therapy of GI tumours expands the range of therapeutic endoscopic procedures in a relatively safe and readily repeatable manner which achieves high patient tolerance. By reducing morbidity, mortality and time spent in hospital, it offers significant advantages in the palliative treatment of conditions previously managed by conventional surgery, and also offers opportunities for treatment of previously inoperable disorders. Developments in laser technology and diagnostic imaging techniques are likely to promote laser therapy in the future as a primary treatment modality. © 1991.
引用
收藏
页码:37 / 59
页数:23
相关论文
共 112 条
  • [1] HEMATOPORPHYRIN DERIVATIVE - QUANTITATIVE UPTAKE IN DIMETHYLHYDRAZINE-INDUCED MURINE COLORECTAL-CARCINOMA
    AGREZ, MV
    WHAREN, RE
    ANDERSON, RE
    LAWS, ER
    ILSTRUP, DM
    CORTESE, DA
    SHORTER, RG
    LIEBER, MM
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1983, 24 (03) : 173 - 176
  • [2] ANDERSON JR, 1987, GUT, V28, pA1374
  • [3] PHOTODYNAMIC THERAPY - ACHIEVEMENTS AND PROSPECTS
    ASH, D
    BROWN, SB
    [J]. BRITISH JOURNAL OF CANCER, 1989, 60 (02) : 151 - 152
  • [4] INTERSTITIAL LASER PHOTOCOAGULATION FOR TREATING BLEEDING GASTRIC-CANCER
    BARR, H
    KRASNER, N
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1989, 299 (6700): : 659 - 660
  • [5] BARR H, 1988, BRIT J SURG, V75, P611
  • [6] Barr H, 1988, Surg Endosc, V2, P44, DOI 10.1007/BF00591398
  • [7] PHOTODYNAMIC THERAPY IN THE NORMAL RAT COLON WITH PHTHALOCYANINE SENSITIZATION
    BARR, H
    TRALAU, CJ
    MACROBERT, AJ
    KRASNER, N
    BOULOS, PB
    CLARK, CG
    BOWN, SG
    [J]. BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 111 - 118
  • [8] BARR H, 1988, GUT, V29, pA729
  • [9] BARR H, 1987, GUT, V28, P1302
  • [10] BARR H, 1990, BRIT J SURG, V31, P252